We are monitoring the impact of COVID-19 on MEA Colorectal Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 562
Share on
Share on

Middle East & Africa Colorectal Cancer Market Research Report – Segmented By Diagnosis, Treatment & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 562
Pages: 138

MEA Colorectal Cancer Market Size (2021 to 2026)

The Colorectal Cancer Market size in the Middle East & Africa was worth USD 1.70 billion in 2021. This value is estimated to be growing at a CAGR of 2.07% to reach USD 1.89 billion by 2026.

An estimated 5000 people from Saudi Arabia are diagnosing with Cancer every year. Growing health awareness and increasing medical tourism in emerging countries are some of the key factors driving the market in this region.

The surgery treatment associated with colorectal cancer is so expensive. It is not affordable by many of the patients is one of the key factors hampering the market in this region.

This research report on the MEA Colorectal Cancer Market has been segmented and sub-segmented into the following categories:

  • By Diagnosis: Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • By Treatment: Surgery And Radiation Therapy, Chemotherapy, Targeted Therapies and Resistance To Pharmacological Therapies
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Regionally, UAE is considered to lead the colorectal cancer of the MEA region, followed by Saudi Arabia. Other significant markets in this region include Zimbabwe, Zambia, Tanzania, and Nigeria. The market in this region has the lowest share due to the general lack of awareness.

Key market players in MEA Colorectal Cancer Market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, and Vaccinogen BD.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 By Diagnosis                                                               

                                5.1.1 Digital Rectal Examination                                 

                                5.1.2 Faecal Occult Blood Test                                    

                                5.1.3 Flexible Sigmoidoscopy                                     

                                5.1.4 Colonoscopy                                          

                                5.1.5 Virtual Colonoscopy                                            

                5.2 By Treatment                                                            

                                5.2.1 Surgery and Radiation Therapy                                      

                                5.2.2 Chemotherapy                                      

                                5.2.3 Targeted Therapies                                             

                                5.2.4 Resistance to Pharmacological Therapies                                   

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Abbott Diagnostics                                                  

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Alere                                                             

                8.3 Beckman Coulter                                                     

                8.4 Clinical Genomics                                                     

                8.5 Companion Dx                                                          

                8.6 Hoffmann La Roche                                                

                8.7 Debiopharm Group                                                 

                8.8 Vaccinogen BD                                                          

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 


                a) List of Tables                                                

                b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Digital Rectal Examination Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Faecal Occult Blood Test Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Flexible Sigmoidoscopy Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Colonoscopy Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Virtual Colonoscopy Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Surgery and Radiation Therapy Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Targeted Therapies Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Resistance to Pharmacological Therapies Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Million)
  14. Middle East Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  15. Africa Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Million)
  16. Africa Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample